Nanjing Sanhome Pharmaceutical, Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Nanjing China (1996)

Organization Overview

First Clinical Trial
2018
NCT03603262
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Nanjing Sanhome Pharmaceutical, Co., Ltd. | No.197 Ruijin Er Road, Shanghai, P.R China